ISA Pharmaceuticals

Showing 2 posts of 2 posts found.

First patient dosed in phase 1 study for chronic hepatitis B treatment

August 31, 2023
Medical Communications Chronic Diseases, ISA Pharmaceuticals, ISA104, clinical trial, hepatitis B

ISA Pharmaceuticals has announced that the first patient has been dosed in its phase 1 HEB-PEP study, assessing the use …

ISA Pharmaceuticals highlights positive clinical data at ASCO

June 6, 2023
Research and Development ASCO, Cancer, HPV, ISA Pharmaceuticals, Oncology

Clinical stage biotechnology company ISA Pharmaceuticals has announced positive phase 1 data at the American Society of Clinical Oncology (ASCO) …

Latest content